Literature for peptidase C16.011: Middle East respiratory syndrome coronavirus papain-like peptidase

(Topics flags: S Structure, T Target, P Specificity, I Inhibitor, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2023
1. Hung,T.I., Hsieh,Y.J., Lu,W.L., Wu,K.P. and Chang,C.A.
   What Strengthens Protein-Protein Interactions: Analysis and Applications of Residue Correlation Networks
   J Mol Biol435, 168337-168337. PubMed  Europe PubMed DOI
2020
2. Henderson,J.A., Verma,N. and Shen,J.
   Assessment of Proton-Coupled Conformational Dynamics of SARS and MERS Coronavirus Papain-like Proteases: Implication for Designing Broad-Spectrum Antiviral Inhibitors
   bioRxiv PubMed  Europe PubMed DOI  T
2019
3. Clasman,J.R., Everett,R.K., Srinivasan,K. and Mesecar,A.D.
   Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease
   Antiviral Res104661-104661. PubMed  Europe PubMed DOI
2017
4. Alfuwaires,M., Altaher,A. and Kandeel,M.
   Molecular dynamic studies of interferon and innate immunity resistance in MERS CoV non-structural protein 3
   Biol Pharm Bull40, 345-351. PubMed  Europe PubMed DOI
5. Clasman,J.R., Baez-Santos,Y.M., Mettelman,R.C., O'Brien,A., Baker,S.C. and Mesecar,A.D.
   X-ray structure and enzymatic activity profile of a core papain-like protease of MERS coronavirus with utility for structure-based drug design
   Sci Rep7, 40292-40292. PubMed  Europe PubMed DOI  S
6. Daczkowski,C.M., Goodwin,O., Dzimianski,J.V., Farhat,J.J. and Pegan,S.D.
   Structurally guided removal of deISGylase biochemical activity from papain-like protease originating from the Middle East respiratory syndrome virus
   J Virol91, e01067-17-e01067-17. PubMed  Europe PubMed DOI
7. Lin,M.H., Moses,D.C., Hsieh,C.H., Cheng,S.C., Chen,Y.H., Sun,C.Y. and Chou,C.Y.
   Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
   Antiviral Res150, 155-163. PubMed  Europe PubMed DOI  I
8. Malik,A. and Alsenaidy,M.A.
   MERS-CoV papain-like protease (PLpro): expression, purification, and spectroscopic/thermodynamic characterization
   3 Biotech7, 100-100. PubMed  Europe PubMed DOI  E
2016
9. Lei,J. and Hilgenfeld,R.
   Structural and mutational analysis of the interaction between the Middle-East respiratory syndrome coronavirus (MERS-CoV) papain-like protease and human ubiquitin
   Virol Sin31, 288-299. PubMed  Europe PubMed DOI  S
2015
10. Cheng,K., Cheng,S., Chen,W., Lin,M., Chuang,S., Cheng,I., Sun,C. and Chou,C.
    Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus
    Antiviral Res115C, 9-16. PubMed  Europe PubMed DOI  I
11. Lee,H., Lei,H., Santarsiero,B.D., Gatuz,J.L., Cao,S., Rice,A.J., Patel,K., Szypulinski,M.Z., Ojeda,I., Ghosh,A.K. and Johnson,M.E.
    Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV
    ACS Chem Biol10, 1456-1465. PubMed  Europe PubMed DOI  P  I
12. Mielech,A.M., Deng,X., Chen,Y., Kindler,E., Wheeler,D.L., Mesecar,A.D., Thiel,V., Perlman,S. and Baker,S.C.
    Murine coronavirus ubiquitin-like domain is important for papain-like protease stability and viral pathogenesis
    J Virol89, 4907-4917. PubMed  Europe PubMed DOI
2014
13. Baez-Santos,Y.M., Mielech,A.M., Deng,X., Baker,S. and Mesecar,A.D.
    Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the middle east respiratory syndrome coronavirus
    J Virol88, 12511-12527. PubMed  Europe PubMed DOI
14. Bailey-Elkin,B.A., Knaap,R.C., Johnson,G.G., Dalebout,T.J., Ninaber,D.K., van Kasteren,P.B., Bredenbeek,P.J., Snijder,E.J., Kikkert,M. and Mark,B.L.
    Crystal structure of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression
    J Biol Chem289, 34667-34682. PubMed  Europe PubMed DOI  S
15. Hilgenfeld,R.
    From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
    FEBS J281, 4085-4096. PubMed  Europe PubMed DOI  V  S
16. Lei,J., Mesters,J.R., Drosten,C., Anemuller,S., Ma,Q. and Hilgenfeld,R.
    Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features
    Antiviral Res109, 72-82. PubMed  Europe PubMed DOI  S
17. Lin,M.H., Chuang,S.J., Chen,C.C., Cheng,S.C., Cheng,K.W., Lin,C.H., Sun,C.Y. and Chou,C.Y.
    Structural and functional characterization of MERS coronavirus papain-like protease
    J Biomed Sci21, 54-54. PubMed  Europe PubMed DOI
18. Mielech,A.M., Kilianski,A., Baez-Santos,Y.M., Mesecar,A.D. and Baker,S.C.
    MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
    Virology450-451, 64-70. PubMed  Europe PubMed DOI
19. Yang,X., Chen,X., Bian,G., Tu,J., Xing,Y., Wang,Y. and Chen,Z.
    Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease
    J Gen Virol95, 614-626. PubMed  Europe PubMed DOI
2013
20. Kilianski,A., Mielech,A.M., Deng,X. and Baker,S.C.
    Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors
    J Virol87, 11955-11962. PubMed  Europe PubMed DOI